In medical research and device development, accurate reporting of clinical trial results is fundamental. Yet, navigating the protocols of global registries, particularly the European Database on Medical Devices (EUDAMED), introduces added complexity.
EUDAMED exemplifies a commitment to enhancing transparency, primarily for patients and healthcare professionals. This centralised system in Europe is poised to become an essential resource, furnishing vital information about medical devices. In this blog, we will explore the pivotal role this database plays in the healthcare sector and its implications for the future.
What is EUDAMED?
The European Database on Medical Devices (EUDAMED) is the IT system facilitating transparent information exchange between the European Commission (EC) and national oversight entities. Established to promote healthcare transparency, the foundation was created in response to regulatory requirements, including the EU medical device regulation MDR 2017/745 and the In Vitro Diagnostic Medical Devices Regulation (EU) 2017/746.
Central to this medical device database is its capacity to provide a comprehensive view of the life cycle of medical devices produced in the European Union (EU) and sold in its markets. Far from being merely a registration tool, EUDAMED functions as an interactive space, permitting stakeholders to catalogue, cooperate, and share information, availing it to the broader public.
The central objectives of the European database for medical devices include:
- Elevating transparency levels for the general populace and medical professionals
- Refining reporting methodologies to eschew duplication
- Improving confidence in the regulatory ecosystem
- Streamlining interactions among economic actors, regulatory bodies, research sponsors, EU Member States, and the Commission.
Modules of EUDAMED
EUDAMED operates with a comprehensive framework comprising six integral modules, supplemented by a publicly accessible website. These modules include the following:
- actor registration
- unique device identifier (UDI) and device specifics
- certifications from notified bodies
- insights from clinical and performance studies
- vigilance protocols and procedures for market surveillance
Within the modules of this medical device database in the EU, users will find diverse data sets, including:
- manufacturer registrations and their designated representatives
- device-specific declarations
- conformance declarations
- systems for monitoring and traceability
- device labelling and user guidelines
- rationale for device classification
- copies of ISO certifications or evidence of a Quality Management System (QMS), among others
The subsequent sections provide an in-depth look at each of these EUDAMED components:
1. Actor registration module
Launched in December 2020, the actor registration module was the inaugural module rolled out for use by key stakeholders. This segment aids
- Regulatory entities (such as the EC, competent/designating authorities, and notified bodies),
- Entities in the medical device database in the European Union sector (including manufacturers, kit/system producers, importers, and designated representatives), and
- Initiators of clinical/performance studies.
This platform facilitates the systematic registration of these various players in the medical device industry.
2. UDI and devices registration module
This module enables manufacturers and producers to manage UDI data for medical devices.
While the module was made accessible in October 2021, certain features like the Clinical Assessment Consultation Procedure (CEDP) and the Review Mechanism remained pending. These elements will be integrated once the European database achieves full operational status with the other modules.
3. Notified bodies and certificates module
An integral part of the classification of medical devices in Europe, this module facilitates communication channels between notified bodies. It prominently features summaries of safety, clinical performance, and the corresponding assessment reports from these bodies.
In addition, EUDAMED oversees various procedures related to notified bodies. Of utmost importance is the process of issuing CE marking certificates. This complex process includes several stages, such as the refusal, restriction, suspension, or revocation of a certificate.
4. Clinical investigation and performance studies module
This clinical investigation module, also crucial for understanding medical device regulation in Europe, is inactive. This is dedicated to handling data from clinical trials and performance studies specifically for IVDs.
The primary entity interacting with this module is the sponsor. Alongside competent authorities, sponsors can issue significant notifications and modify the study’s ongoing status.
5. Vigilance and post-market surveillance module
The vigilance module, similar to the clinical research module, is currently unavailable. It will operate through the coordinated efforts of multiple stakeholders. Manufacturers must report all incidents, including anticipated outcomes with a surge in frequency or severity.
6. Market surveillance module
As previously outlined, a segment of the European database is specifically designed to enhance collaboration and coordination among Member States. Through this sixth module, Member States can upload summaries of their market surveillance findings and detailed reports from inspections conducted on economic entities.
Although most of this data will be kept within the interactions between competent authorities and the Commission, notified bodies can also access the information regarding device certifications in cases where they are involved. Additionally, summary reports outlining the market surveillance efforts of Member States will be made available to the public.
Deadline to Register in European Database on Medical Devices
As of now, participation in the European database on medical devices remains voluntary. Multiple delays have occurred despite the initial plans for EUDAMED to be fully functional by May 26, 2020. The revised schedule suggests the following:
- EUDAMED reaching its complete functionality by Q2 2027
- A delay primarily due to the clinical investigation and performance studies module to be ready for an audit by Q3 2026
- All six modules audit ready by Q4 2026
Assuming a successful audit conclusion by Q2 2027, the operational status of the medical device database will be announced in the Official Journal of the EU (OJEU).
Subsequent transition periods are as follows:
- Mandatory use by Q4 2027 for actor, vigilance, market surveillance, and clinical investigation and performance studies modules after a six-month transition
- UDI/device registration notified body and certificates become obligatory by Q2 2029, after a 24-month transition
For a detailed view, refer to the official EUDAMED roadmap draft.
Bottomline
The European Database on Medical Devices represents the European Commission’s systematic approach to centralising medical device data, promoting transparency, and enhancing regulatory collaboration across the EU. With the gradual operation of its modules, stakeholders can expect a framework for medical device oversight that is more streamlined and transparent. This progress highlights the significance of shared information in the healthcare domain, paving the way for safer and more informed medical practices across the continent.
Navigate Medical Device Regulations with Vicki’s Expertise
Understanding the EUDAMED landscape is crucial for navigating the intricacies of medical device regulations in the EU. If you’re looking to align your business with the latest regulatory requirements, whether in Australia, the US, or Europe, Vicki Partridge’s three decades of expertise can guide you through.
Enhance your knowledge and streamline your regulatory process with a trusted consultant. Contact Vicki Partridge today at vicki@vickipartridge.com.au or +61 7 55295508 for tailored solutions.